# Strategy, Efficacy and Safety of Medication Usage in Heart Failure Patients Who Were Intolerable to GDMT

> **NCT05799638** · — · COMPLETED · sponsor: **Chongqing Medical University** · enrollment: 263 (actual)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction

## Interventions

- **OTHER:** Guideline-Directed Medication Treatment (GDMT)

## Key facts

- **NCT ID:** NCT05799638
- **Lead sponsor:** Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 263 (ACTUAL)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05799638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05799638, "Strategy, Efficacy and Safety of Medication Usage in Heart Failure Patients Who Were Intolerable to GDMT". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT05799638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*